Adaptation to chronic continuous hypoxia potentiates Akt/HK2 anti-apoptotic pathway during brief myocardial ischemia/reperfusion insult. 2017

David Kolar, and Milada Gresikova, and Petra Waskova-Arnostova, and Barbara Elsnicova, and Jana Kohutova, and Daniela Hornikova, and Pavel Vebr, and Jan Neckar, and Tereza Blahova, and Dita Kasparova, and Jiri Novotny, and Frantisek Kolar, and Olga Novakova, and Jitka M Zurmanova
Department of Physiology, Faculty of Science, Charles University in Prague, Prague, Czech Republic.

Adaptation to chronic hypoxia represents a potential cardioprotective intervention reducing the extent of acute ischemia/reperfusion (I/R) injury, which is a major cause of death worldwide. The main objective of this study was to investigate the anti-apoptotic Akt/hexokinase 2 (HK2) pathway in hypoxic hearts subjected to I/R insult. Hearts isolated from male Wistar rats exposed either to continuous normobaric hypoxia (CNH; 10% O2) or to room air for 3 weeks were perfused according to Langendorff and subjected to 10 min of no-flow ischemia and 10 min of reperfusion. The hearts were collected either after ischemia or after reperfusion and used for protein analyses and quantitative fluorescence microscopy. The CNH resulted in increased levels of HK1 and HK2 proteins and the total HK activity after ischemia compared to corresponding normoxic group. Similarly, CNH hearts exhibited increased ischemic level of Akt protein phosphorylated on Ser473. The CNH also strengthened the interaction of HK2 with mitochondria and prevented downregulation of mitochondrial creatine kinase after reperfusion. The Bax/Bcl-2 ratio was significantly lower after I/R in CNH hearts than in normoxic ones, suggesting a lower probability of apoptosis. In conclusion, the Akt/HK2 pathway is likely to play a role in the development of a cardioprotective phenotype of CNH by preventing the detachment of HK2 from mitochondria at reperfusion period and decreases the Bax/Bcl-2 ratio during I/R insult, thereby lowering the probability of apoptosis activation in the mitochondrial compartment.

UI MeSH Term Description Entries
D008297 Male Males
D008929 Mitochondria, Heart The mitochondria of the myocardium. Heart Mitochondria,Myocardial Mitochondria,Mitochondrion, Heart,Heart Mitochondrion,Mitochondria, Myocardial
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D006593 Hexokinase An enzyme that catalyzes the conversion of ATP and a D-hexose to ADP and a D-hexose 6-phosphate. D-Glucose, D-mannose, D-fructose, sorbitol, and D-glucosamine can act as acceptors; ITP and dATP can act as donors. The liver isoenzyme has sometimes been called glucokinase. (From Enzyme Nomenclature, 1992) EC 2.7.1.1. Hexokinase A,Hexokinase D,Hexokinase II
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015428 Myocardial Reperfusion Injury Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm. Reperfusion Injury, Myocardial,Injury, Myocardial Reperfusion,Myocardial Ischemic Reperfusion Injury,Injuries, Myocardial Reperfusion,Myocardial Reperfusion Injuries,Reperfusion Injuries, Myocardial
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051057 Proto-Oncogene Proteins c-akt Protein-serine-threonine kinases that contain PLECKSTRIN HOMOLOGY DOMAINS and are activated by PHOSPHORYLATION in response to GROWTH FACTORS or INSULIN. They play a major role in cell metabolism, growth, and survival as a core component of SIGNAL TRANSDUCTION. Three isoforms have been described in mammalian cells. akt Proto-Oncogene Protein,c-akt Protein,AKT1 Protein Kinase,AKT2 Protein Kinase,AKT3 Protein Kinase,Akt-alpha Protein,Akt-beta Protein,Akt-gamma Protein,Protein Kinase B,Protein Kinase B alpha,Protein Kinase B beta,Protein Kinase B gamma,Protein-Serine-Threonine Kinase (Rac),Proto-Oncogene Protein Akt,Proto-Oncogene Protein RAC,Proto-Oncogene Proteins c-akt1,Proto-Oncogene Proteins c-akt2,Proto-Oncogene Proteins c-akt3,RAC-PK Protein,Rac Protein Kinase,Rac-PK alpha Protein,Rac-PK beta Protein,Related to A and C-Protein,c-akt Proto-Oncogene Protein,Akt alpha Protein,Akt beta Protein,Akt gamma Protein,Akt, Proto-Oncogene Protein,Protein, akt Proto-Oncogene,Protein, c-akt Proto-Oncogene,Proteins c-akt1, Proto-Oncogene,Proteins c-akt2, Proto-Oncogene,Proteins c-akt3, Proto-Oncogene,Proto Oncogene Protein Akt,Proto Oncogene Protein RAC,Proto Oncogene Proteins c akt,Proto Oncogene Proteins c akt1,Proto Oncogene Proteins c akt2,Proto Oncogene Proteins c akt3,Proto-Oncogene Protein, akt,Proto-Oncogene Protein, c-akt,RAC PK Protein,RAC, Proto-Oncogene Protein,Rac PK alpha Protein,Rac PK beta Protein,Related to A and C Protein,akt Proto Oncogene Protein,alpha Protein, Rac-PK,c akt Proto Oncogene Protein,c-akt, Proto-Oncogene Proteins,c-akt1, Proto-Oncogene Proteins,c-akt2, Proto-Oncogene Proteins,c-akt3, Proto-Oncogene Proteins
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

David Kolar, and Milada Gresikova, and Petra Waskova-Arnostova, and Barbara Elsnicova, and Jana Kohutova, and Daniela Hornikova, and Pavel Vebr, and Jan Neckar, and Tereza Blahova, and Dita Kasparova, and Jiri Novotny, and Frantisek Kolar, and Olga Novakova, and Jitka M Zurmanova
January 2017, PloS one,
David Kolar, and Milada Gresikova, and Petra Waskova-Arnostova, and Barbara Elsnicova, and Jana Kohutova, and Daniela Hornikova, and Pavel Vebr, and Jan Neckar, and Tereza Blahova, and Dita Kasparova, and Jiri Novotny, and Frantisek Kolar, and Olga Novakova, and Jitka M Zurmanova
June 1994, Annals of the New York Academy of Sciences,
David Kolar, and Milada Gresikova, and Petra Waskova-Arnostova, and Barbara Elsnicova, and Jana Kohutova, and Daniela Hornikova, and Pavel Vebr, and Jan Neckar, and Tereza Blahova, and Dita Kasparova, and Jiri Novotny, and Frantisek Kolar, and Olga Novakova, and Jitka M Zurmanova
March 2003, Zhonghua nei ke za zhi,
David Kolar, and Milada Gresikova, and Petra Waskova-Arnostova, and Barbara Elsnicova, and Jana Kohutova, and Daniela Hornikova, and Pavel Vebr, and Jan Neckar, and Tereza Blahova, and Dita Kasparova, and Jiri Novotny, and Frantisek Kolar, and Olga Novakova, and Jitka M Zurmanova
January 2013, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
David Kolar, and Milada Gresikova, and Petra Waskova-Arnostova, and Barbara Elsnicova, and Jana Kohutova, and Daniela Hornikova, and Pavel Vebr, and Jan Neckar, and Tereza Blahova, and Dita Kasparova, and Jiri Novotny, and Frantisek Kolar, and Olga Novakova, and Jitka M Zurmanova
December 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
David Kolar, and Milada Gresikova, and Petra Waskova-Arnostova, and Barbara Elsnicova, and Jana Kohutova, and Daniela Hornikova, and Pavel Vebr, and Jan Neckar, and Tereza Blahova, and Dita Kasparova, and Jiri Novotny, and Frantisek Kolar, and Olga Novakova, and Jitka M Zurmanova
October 2014, Inflammation,
David Kolar, and Milada Gresikova, and Petra Waskova-Arnostova, and Barbara Elsnicova, and Jana Kohutova, and Daniela Hornikova, and Pavel Vebr, and Jan Neckar, and Tereza Blahova, and Dita Kasparova, and Jiri Novotny, and Frantisek Kolar, and Olga Novakova, and Jitka M Zurmanova
August 2022, Biomedicines,
David Kolar, and Milada Gresikova, and Petra Waskova-Arnostova, and Barbara Elsnicova, and Jana Kohutova, and Daniela Hornikova, and Pavel Vebr, and Jan Neckar, and Tereza Blahova, and Dita Kasparova, and Jiri Novotny, and Frantisek Kolar, and Olga Novakova, and Jitka M Zurmanova
September 1996, Annals of the New York Academy of Sciences,
David Kolar, and Milada Gresikova, and Petra Waskova-Arnostova, and Barbara Elsnicova, and Jana Kohutova, and Daniela Hornikova, and Pavel Vebr, and Jan Neckar, and Tereza Blahova, and Dita Kasparova, and Jiri Novotny, and Frantisek Kolar, and Olga Novakova, and Jitka M Zurmanova
May 2017, Biochemical and biophysical research communications,
David Kolar, and Milada Gresikova, and Petra Waskova-Arnostova, and Barbara Elsnicova, and Jana Kohutova, and Daniela Hornikova, and Pavel Vebr, and Jan Neckar, and Tereza Blahova, and Dita Kasparova, and Jiri Novotny, and Frantisek Kolar, and Olga Novakova, and Jitka M Zurmanova
January 2013, Journal of Asian natural products research,
Copied contents to your clipboard!